CHERRIELYN ESCONO-QUIAMBAO: Open Payments
NPI 1437697745 · HACKETTSTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$824 in 41 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $62 · 2025 $824
Food & beverage: $805Education: $20
| Company | Payments | Amount |
|---|---|---|
| Avadel CNS Pharmaceuticals, LLC | 2 | $140 |
| GlaxoSmithKline, LLC. | 7 | $116 |
| Novo Nordisk Inc | 6 | $102 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| Tactile Systems Technology Inc | 2 | $44 |
| Lilly USA, LLC | 2 | $37 |
| Insmed, Inc. | 2 | $37 |
| Gilead Sciences, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Grifols USA, LLC | 2 | $32 |
Products named: LUMRYZ, Kerendia, NUCALA, TRELEGY ELLIPTA, Rybelsus, Flexitouch Plus, Arikayce, Veklury.
Industry payments across NJ — which companies pay providers there.
